Related Experiment Videos
Oral methylene blue and the dissolution of renal calculi
The Journal of Urology
|August 1, 1976
Abstract:
Oral methylene blue therapy was not effective in dissolving non-obstructive renal calculi in 26 patients but it may prevent new stone formation in patients with metabolically active urolithiasis. The use of methylene blue therapy in combination with other regimens having different mechanisms of stone inhibition is recommended to further improve results.
Insights
Oral methylene blue did not dissolve kidney stones in patients. However, this therapy may help prevent new stones in those with metabolic urolithiasis, suggesting combination treatments could be beneficial.
Area of Science:
- Nephrology
- Urology
- Pharmacology
Background:
- Renal calculi (kidney stones) pose a significant health challenge.
- Metabolically active urolithiasis requires effective treatment strategies.
- Methylene blue is explored for its potential therapeutic effects in stone management.
Purpose of the Study:
- To evaluate the efficacy of oral methylene blue in dissolving non-obstructive renal calculi.
- To assess the potential of methylene blue in preventing new stone formation in patients with metabolic urolithiasis.
Main Methods:
- A study involving 26 patients with non-obstructive renal calculi.
- Administration of oral methylene blue therapy.
- Observation for stone dissolution and new stone formation.
Main Results:
- Oral methylene blue therapy was ineffective in dissolving existing non-obstructive renal calculi.
- Methylene blue demonstrated potential in preventing the formation of new stones in patients with metabolically active urolithiasis.
Conclusions:
- Methylene blue is not effective for dissolving current kidney stones.
- Methylene blue may offer preventive benefits for new stone formation in specific patient groups.
- Combination therapy with other stone inhibition regimens is recommended for improved outcomes.